ESOMEPRAZOLE MAGNESIUM

ESOMEPRAZOLE MAGNESIUM was reported 234522 times

ESOMEPRAZOLE MAGNESIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RENAL HAEMANGIOMA 789 0.9900
1 REBOUND ACID HYPERSECRETION 2506 0.8276
2 CARDIOSPASM 400 0.7168
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 723 0.6808
4 NEPHROGENIC ANAEMIA 2916 0.6289
5 IMMUNISATION 252 0.5806
6 END STAGE RENAL DISEASE 10301 0.5642
7 HYPERPARATHYROIDISM SECONDARY 1389 0.5538
8 PALMOPLANTAR KERATODERMA 390 0.5379
9 NEUROLOGIC NEGLECT SYNDROME 288 0.5180
10 CHRONIC KIDNEY DISEASE 35587 0.4679
11 HYPERTENSIVE NEPHROPATHY 429 0.4021
12 SENSITISATION 293 0.3860
13 EJECTION FRACTION 221 0.3804
14 CAROTID ARTERY THROMBOSIS 305 0.3592
15 HYPERCHLORHYDRIA 1962 0.3331
16 RENAL INJURY 9529 0.3205
17 BARRETT'S OESOPHAGUS 245 0.3043
18 CALCIUM DEFICIENCY 327 0.2523
19 ADJUSTMENT DISORDER 298 0.2292
20 TUBULOINTERSTITIAL NEPHRITIS 4259 0.2270
21 ATRIAL TACHYCARDIA 438 0.2084
22 AMAUROSIS FUGAX 223 0.2071
23 DIABETIC NEPHROPATHY 428 0.1943
24 CATARRH 174 0.1925
25 POLYCYSTIC OVARIES 297 0.1914
26 STEROID DEPENDENCE 165 0.1879
27 APHAGIA 881 0.1829
28 REGURGITATION 613 0.1783
29 NEPHROSCLEROSIS 195 0.1755
30 PRURITUS GENITAL 404 0.1714
31 ADENOCARCINOMA GASTRIC 149 0.1604
32 GASTRIC POLYPS 343 0.1517
33 GASTROOESOPHAGEAL REFLUX DISEASE 12006 0.1490
34 EROSIVE OESOPHAGITIS 234 0.1380
35 REBOUND EFFECT 1551 0.1371
36 PERSONALITY DISORDER 353 0.1346
37 NEPHROPATHY 1253 0.1341
38 ACUTE KIDNEY INJURY 20516 0.1339
39 CAROTID ARTERY OCCLUSION 475 0.1301
40 PHYSICAL DECONDITIONING 333 0.1293
41 ESSENTIAL HYPERTENSION 232 0.1266
42 RENAL ATROPHY 155 0.1241
43 RENAL FAILURE 16278 0.1225
44 OESOPHAGEAL DISORDER 455 0.1181
45 BILIARY DYSKINESIA 198 0.1166
46 HIATUS HERNIA 1469 0.1133
47 TENSION HEADACHE 466 0.1083
48 BURNS SECOND DEGREE 187 0.1065
49 NEPHRECTOMY 156 0.1050
50 INTENTIONAL DRUG MISUSE 2179 0.1041
51 RHINITIS ALLERGIC 453 0.1017
52 OESOPHAGEAL PAIN 397 0.1004
53 SLEEP TERROR 402 0.0954
54 MULTIPLE FRACTURES 1565 0.0952
55 OESOPHAGEAL SPASM 164 0.0889
56 OSTEOPOROSIS 3182 0.0773
57 BLOOD PRESSURE SYSTOLIC ABNORMAL 191 0.0772
58 CYTOLYTIC HEPATITIS 250 0.0752
59 RHEUMATOID NODULE 206 0.0747
60 RENAL CYST 577 0.0726
61 VITAMIN D DEFICIENCY 696 0.0713
62 DYSPEPSIA 6664 0.0677
63 CHOLECYSTITIS CHRONIC 452 0.0675
64 DRUG DOSE OMISSION 11125 0.0672
65 RENAL TUBULAR NECROSIS 644 0.0656
66 EPIGASTRIC DISCOMFORT 255 0.0652
67 ULCER 1033 0.0649
68 BLOOD PRESSURE DIASTOLIC ABNORMAL 165 0.0648
69 SPINAL OSTEOARTHRITIS 551 0.0627
70 OESOPHAGEAL STENOSIS 178 0.0625
71 HYPOPNOEA 217 0.0625
72 HYPOMAGNESAEMIA 861 0.0618
73 MAJOR DEPRESSION 449 0.0614
74 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 386 0.0594
75 BODY HEIGHT DECREASED 632 0.0590
76 PEPTIC ULCER 196 0.0590
77 OSTEOPENIA 896 0.0590
78 VITAMIN B12 DEFICIENCY 239 0.0590
79 INTERVERTEBRAL DISC DEGENERATION 546 0.0590
80 FACIAL PAIN 521 0.0583
81 URINARY TRACT DISORDER 260 0.0577
82 BONE DISORDER 1048 0.0575
83 HEMIPLEGIA 475 0.0570
84 ALCOHOL POISONING 152 0.0567
85 LUMBAR SPINAL STENOSIS 155 0.0530
86 OESOPHAGITIS 570 0.0521
87 GASTRIC DISORDER 1789 0.0521
88 SUBARACHNOID HAEMORRHAGE 530 0.0520
89 OESOPHAGEAL ULCER 200 0.0520
90 SPINAL COLUMN STENOSIS 242 0.0512
91 DIASTOLIC DYSFUNCTION 157 0.0508
92 POLYP 333 0.0508
93 ERUCTATION 980 0.0506
94 GASTRITIS 1327 0.0504
95 ARTERIAL OCCLUSIVE DISEASE 391 0.0497
96 SLEEP APNOEA SYNDROME 944 0.0494
97 DIVERTICULUM 349 0.0491
98 LOSS OF EMPLOYMENT 148 0.0490
99 AZOTAEMIA 195 0.0488
100 CARPAL TUNNEL SYNDROME 683 0.0487
101 GASTRITIS EROSIVE 227 0.0486
102 INTERVERTEBRAL DISC DISORDER 205 0.0480
103 SENSORY LOSS 385 0.0478
104 GANGRENE 284 0.0471
105 VASCULITIS 547 0.0469
106 RHINITIS 374 0.0463
107 DIALYSIS 655 0.0461
108 FIBROMYALGIA 1119 0.0460
109 HAEMORRHAGIC STROKE 353 0.0452
110 DYSLIPIDAEMIA 229 0.0450
111 CARDIAC MURMUR 382 0.0441
112 CANDIDIASIS 176 0.0438
113 SYNOVIAL CYST 199 0.0431
114 HYPERLIPIDAEMIA 514 0.0430
115 CAROTID ARTERY STENOSIS 149 0.0426
116 VENTRICULAR TACHYCARDIA 703 0.0425
117 DIABETIC NEUROPATHY 209 0.0422
118 BLOOD MAGNESIUM DECREASED 361 0.0418
119 MOTOR DYSFUNCTION 425 0.0417
120 CHRONIC SINUSITIS 156 0.0415
121 INCREASED UPPER AIRWAY SECRETION 213 0.0414
122 GINGIVAL PAIN 330 0.0414
123 DIVERTICULUM INTESTINAL 181 0.0414
124 BRONCHIECTASIS 278 0.0412
125 HEARING IMPAIRED 247 0.0411
126 IRON DEFICIENCY ANAEMIA 380 0.0411
127 ULCER HAEMORRHAGE 277 0.0409
128 BREATH SOUNDS ABNORMAL 198 0.0401
129 ATELECTASIS 387 0.0400
130 GASTRIC ULCER 754 0.0396
131 INTENTIONAL PRODUCT MISUSE 3465 0.0395
132 HYPOCALCAEMIA 731 0.0386
133 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 396 0.0385
134 FOOT FRACTURE 720 0.0379
135 AFFECT LABILITY 365 0.0379
136 DIPLOPIA 984 0.0378
137 ARTHRITIS 2978 0.0378
138 ANKLE FRACTURE 583 0.0376
139 LEFT VENTRICULAR HYPERTROPHY 161 0.0376
140 SCOLIOSIS 233 0.0376
141 OSTEOARTHRITIS 1589 0.0374
142 PERIPHERAL VASCULAR DISORDER 192 0.0372
143 CHOLECYSTITIS ACUTE 211 0.0372
144 LARGE INTESTINE POLYP 256 0.0369
145 RENAL FAILURE CHRONIC 284 0.0369
146 COORDINATION ABNORMAL 515 0.0369
147 BLOOD PRESSURE DIASTOLIC DECREASED 271 0.0367
148 FEBRILE BONE MARROW APLASIA 156 0.0367
149 EMPHYSEMA 368 0.0364
150 HAEMORRHAGIC ANAEMIA 160 0.0364
151 MALNUTRITION 405 0.0362
152 SPINAL COMPRESSION FRACTURE 298 0.0360
153 IRON DEFICIENCY 162 0.0360
154 CHOLESTASIS 691 0.0360
155 SINUS CONGESTION 486 0.0359
156 GENERALISED OEDEMA 445 0.0359
157 TINNITUS 1642 0.0357
158 MULTIPLE ALLERGIES 279 0.0356
159 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 604 0.0355
160 MITRAL VALVE INCOMPETENCE 396 0.0350
161 TRANSIENT ISCHAEMIC ATTACK 1180 0.0349
162 INTERVERTEBRAL DISC PROTRUSION 764 0.0349
163 PROTEINURIA 664 0.0349
164 TRICUSPID VALVE INCOMPETENCE 276 0.0347
165 ANOSMIA 500 0.0345
166 EXOSTOSIS 315 0.0345
167 SINUS DISORDER 680 0.0343
168 POST-TRAUMATIC STRESS DISORDER 230 0.0343
169 AORTIC VALVE INCOMPETENCE 146 0.0343
170 PATHOLOGICAL FRACTURE 174 0.0343
171 EATING DISORDER 730 0.0342
172 BACK INJURY 371 0.0341
173 PAROSMIA 257 0.0340
174 HAEMATEMESIS 860 0.0339
175 GALLBLADDER DISORDER 605 0.0339
176 WRIST FRACTURE 405 0.0338
177 THROAT IRRITATION 1515 0.0337
178 HAEMODIALYSIS 283 0.0337
179 GASTRIC ULCER HAEMORRHAGE 186 0.0335
180 RENAL IMPAIRMENT 2812 0.0334
181 BACK DISORDER 544 0.0334
182 PHLEBITIS 171 0.0334
183 PERICARDITIS 561 0.0334
184 ODYNOPHAGIA 199 0.0333
185 TOXIC SKIN ERUPTION 334 0.0331
186 CROHN'S DISEASE 227 0.0331
187 HYPOTHYROIDISM 1046 0.0327
188 NEPHROLITHIASIS 1502 0.0327
189 PHARYNGOLARYNGEAL PAIN 174 0.0327
190 RENAL DISORDER 1522 0.0326
191 ANGINA PECTORIS 935 0.0326
192 NOCTURIA 396 0.0326
193 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1695 0.0325
194 WRONG DRUG ADMINISTERED 289 0.0324
195 TIBIA FRACTURE 152 0.0324
196 GASTROINTESTINAL MOTILITY DISORDER 173 0.0323
197 CORONARY ARTERY OCCLUSION 440 0.0321
198 SENSATION OF FOREIGN BODY 270 0.0320
199 HYPOKALAEMIA 1478 0.0320
200 MALABSORPTION 167 0.0319
201 CHOLECYSTITIS 379 0.0318
202 CHOKING 620 0.0317
203 ABDOMINAL PAIN UPPER 6494 0.0315
204 CORONARY ARTERY DISEASE 955 0.0315
205 BLOOD TEST ABNORMAL 441 0.0314
206 STOMACH DISCOMFORT 162 0.0313
207 CORONARY ARTERY STENOSIS 157 0.0312
208 ANGINA UNSTABLE 202 0.0310
209 HAND FRACTURE 220 0.0310
210 AGRANULOCYTOSIS 577 0.0310
211 MUSCLE SPASTICITY 381 0.0310
212 RIB FRACTURE 635 0.0308
213 BENIGN PROSTATIC HYPERPLASIA 159 0.0308
214 PRE-EXISTING CONDITION IMPROVED 192 0.0307
215 CARDIOMEGALY 377 0.0306
216 THYROID DISORDER 471 0.0305
217 HEMIPARESIS 517 0.0305
218 CHOKING SENSATION 168 0.0304
219 NERVE INJURY 337 0.0303
220 ROTATOR CUFF SYNDROME 388 0.0302
221 RESPIRATORY TRACT CONGESTION 480 0.0302
222 HAEMATURIA 1030 0.0300
223 DIABETES MELLITUS 2289 0.0300
224 IRRITABLE BOWEL SYNDROME 643 0.0300
225 GLUCOSE TOLERANCE IMPAIRED 177 0.0299
226 RED BLOOD CELL SEDIMENTATION RATE INCREASED 331 0.0299
227 HERNIA 577 0.0298
228 BLOOD CHOLESTEROL INCREASED 1391 0.0298
229 DYSPHAGIA 2831 0.0298
230 MUSCULOSKELETAL DISCOMFORT 513 0.0298
231 BURSITIS 361 0.0297
232 CHOLANGITIS 184 0.0296
233 SPINAL DISORDER 281 0.0296
234 VITAMIN D DECREASED 253 0.0296
235 INTERSTITIAL LUNG DISEASE 1431 0.0295
236 HYPERCHOLESTEROLAEMIA 285 0.0295
237 STRESS FRACTURE 159 0.0294
238 JOINT EFFUSION 203 0.0294
239 IMPAIRED GASTRIC EMPTYING 401 0.0294
240 PANCREATITIS ACUTE 658 0.0292
241 HEPATOCELLULAR INJURY 415 0.0292
242 HYDRONEPHROSIS 219 0.0292
243 RALES 169 0.0291
244 PYELONEPHRITIS 252 0.0291
245 CHOLELITHIASIS 953 0.0290
246 FAECES DISCOLOURED 627 0.0289
247 HYPONATRAEMIA 1628 0.0289
248 FLATULENCE 1636 0.0288
249 RENAL FAILURE ACUTE 1224 0.0288
250 HAEMORRHOIDS 561 0.0287
251 MUSCULOSKELETAL CHEST PAIN 443 0.0286
252 HEPATIC STEATOSIS 533 0.0286
253 COMPRESSION FRACTURE 153 0.0285
254 SWOLLEN TONGUE 889 0.0284
255 ABDOMINAL DISCOMFORT 4770 0.0284
256 HEPATITIS CHOLESTATIC 170 0.0282
257 ARTERIOSCLEROSIS 265 0.0281
258 DYSPHONIA 1643 0.0281
259 METABOLIC ACIDOSIS 897 0.0280
260 HEPATIC CYTOLYSIS 357 0.0280
261 FLANK PAIN 261 0.0278
262 HYPERKALAEMIA 975 0.0278
263 ENTEROCOLITIS 160 0.0277
264 UPPER LIMB FRACTURE 552 0.0277
265 BLOOD IRON DECREASED 327 0.0275
266 ARTERIOSCLEROSIS CORONARY ARTERY 181 0.0273
267 MUSCLE TWITCHING 629 0.0273
268 CHEST PAIN 5045 0.0272
269 SEROTONIN SYNDROME 523 0.0272
270 KIDNEY INFECTION 534 0.0272
271 CATARACT 1609 0.0270
272 ALTERED STATE OF CONSCIOUSNESS 585 0.0270
273 ASPIRATION 295 0.0269
274 TYPE 1 DIABETES MELLITUS 162 0.0269
275 BIPOLAR DISORDER 291 0.0267
276 HYPOALBUMINAEMIA 208 0.0267
277 SPINAL FRACTURE 536 0.0267
278 DIVERTICULITIS 733 0.0264
279 GASTROENTERITIS 386 0.0264
280 BRONCHITIS 1956 0.0264
281 BLOOD PRESSURE SYSTOLIC INCREASED 514 0.0263
282 UPPER-AIRWAY COUGH SYNDROME 217 0.0263
283 EOSINOPHILIA 456 0.0260
284 COLITIS ISCHAEMIC 175 0.0259
285 OCULAR DISCOMFORT 291 0.0259
286 ECONOMIC PROBLEM 392 0.0258
287 NIGHTMARE 893 0.0258
288 SHOCK HAEMORRHAGIC 209 0.0256
289 DUODENAL ULCER 181 0.0256
290 DYSURIA 944 0.0256
291 PLEURISY 152 0.0256
292 GASTRIC CANCER 648 0.0256
293 HYPOVOLAEMIA 149 0.0254
294 BLINDNESS 1037 0.0254
295 POLYURIA 208 0.0254
296 LIGAMENT SPRAIN 251 0.0254
297 MOUTH HAEMORRHAGE 186 0.0253
298 DERMATITIS BULLOUS 183 0.0253
299 CLOSTRIDIUM DIFFICILE COLITIS 268 0.0252
300 ANGIOEDEMA 1116 0.0252
301 TYPE 2 DIABETES MELLITUS 849 0.0252
302 RASH MACULO-PAPULAR 560 0.0251
303 CYSTITIS 801 0.0251
304 PHOTOPHOBIA 472 0.0251
305 MENISCUS INJURY 154 0.0250
306 HYPOPHOSPHATAEMIA 185 0.0250
307 MUSCLE STRAIN 216 0.0249
308 ACUTE RESPIRATORY FAILURE 480 0.0249
309 ATRIOVENTRICULAR BLOCK COMPLETE 167 0.0249
310 CYST 309 0.0249
311 TENDERNESS 259 0.0248
312 ATRIAL FLUTTER 198 0.0248
313 SEDATION 649 0.0248
314 PULMONARY HYPERTENSION 516 0.0247
315 JOINT INJURY 526 0.0246
316 HEPATIC ENCEPHALOPATHY 229 0.0245
317 PNEUMONIA ASPIRATION 610 0.0244
318 CONCUSSION 189 0.0244
319 IMPAIRED WORK ABILITY 521 0.0243
320 URINE OUTPUT DECREASED 213 0.0243
321 EXTRASYSTOLES 169 0.0242
322 APHASIA 727 0.0240
323 BLOOD UREA INCREASED 402 0.0240
324 APHONIA 335 0.0240
325 JOINT DISLOCATION 253 0.0239
326 C-REACTIVE PROTEIN INCREASED 868 0.0238
327 BONE DENSITY DECREASED 747 0.0238
328 PERICARDIAL EFFUSION 550 0.0238
329 ACUTE CORONARY SYNDROME 197 0.0238
330 ACTIVITIES OF DAILY LIVING IMPAIRED 469 0.0237
331 RECTAL HAEMORRHAGE 1017 0.0236
332 ADRENAL INSUFFICIENCY 287 0.0236
333 SEPTIC SHOCK 1029 0.0236
334 HEAD DISCOMFORT 418 0.0236
335 ASCITES 693 0.0236
336 MICTURITION URGENCY 269 0.0235
337 PULMONARY CONGESTION 310 0.0235
338 BLOOD TRIGLYCERIDES INCREASED 414 0.0234
339 FOOT DEFORMITY 259 0.0233
340 BLOOD ALKALINE PHOSPHATASE INCREASED 580 0.0233
341 BLOOD CALCIUM DECREASED 262 0.0233
342 GASTRIC HAEMORRHAGE 268 0.0233
343 LUNG INFILTRATION 204 0.0231
344 GLAUCOMA 444 0.0230
345 HYPERTENSION 4857 0.0229
346 OBSTRUCTIVE AIRWAYS DISORDER 255 0.0229
347 GAMMA-GLUTAMYLTRANSFERASE INCREASED 508 0.0229
348 SINUSITIS 2346 0.0229
349 ANURIA 197 0.0229
350 VENTRICULAR EXTRASYSTOLES 237 0.0228
351 ELECTROLYTE IMBALANCE 265 0.0228
352 BLOOD PRESSURE FLUCTUATION 547 0.0228
353 MALAISE 9988 0.0228
354 SUPRAVENTRICULAR TACHYCARDIA 218 0.0227
355 MYOCARDIAL ISCHAEMIA 259 0.0227
356 NEPHROTIC SYNDROME 156 0.0227
357 DRUG INTERACTION 3605 0.0227
358 PELVIC FRACTURE 176 0.0226
359 HYPERCALCAEMIA 279 0.0226
360 BODY TEMPERATURE DECREASED 222 0.0225
361 DRUG ERUPTION 399 0.0225
362 CHOLECYSTECTOMY 257 0.0225
363 LOWER LIMB FRACTURE 431 0.0224
364 RESTLESS LEGS SYNDROME 407 0.0224
365 ANOREXIA 288 0.0223
366 TOXIC EPIDERMAL NECROLYSIS 339 0.0223
367 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 173 0.0222
368 MELAENA 490 0.0222
369 AMNESIA 1443 0.0222
370 RASH PAPULAR 497 0.0222
371 NEUTROPHIL COUNT INCREASED 227 0.0221
372 DENTAL CARIES 245 0.0221
373 SINUS BRADYCARDIA 213 0.0220
374 ORAL CANDIDIASIS 290 0.0220
375 HEART RATE IRREGULAR 497 0.0220
376 OEDEMA PERIPHERAL 2674 0.0219
377 DEHYDRATION 2926 0.0219
378 LUNG DISORDER 1074 0.0219
379 URINARY INCONTINENCE 646 0.0218
380 HELICOBACTER INFECTION 224 0.0218
381 HAEMATOCRIT DECREASED 432 0.0218
382 LIP SWELLING 724 0.0217
383 BURNING SENSATION 1520 0.0217
384 EAR PAIN 421 0.0216
385 SNEEZING 485 0.0216
386 MUSCULAR WEAKNESS 2454 0.0216
387 DYSARTHRIA 810 0.0215
388 HAEMOPTYSIS 600 0.0215
389 SKIN ULCER 556 0.0215
390 BLOOD POTASSIUM DECREASED 645 0.0214
391 PALPITATIONS 2510 0.0214
392 PULMONARY FIBROSIS 411 0.0214
393 BASAL CELL CARCINOMA 334 0.0214
394 RIGHT VENTRICULAR FAILURE 150 0.0214
395 CARDIAC FAILURE CONGESTIVE 1714 0.0213
396 MUSCULOSKELETAL PAIN 1114 0.0212
397 RHABDOMYOLYSIS 882 0.0211
398 NERVE COMPRESSION 195 0.0211
399 CHEST DISCOMFORT 2162 0.0211
400 PRESYNCOPE 513 0.0211
401 UPPER RESPIRATORY TRACT INFECTION 970 0.0210
402 ANAEMIA 3998 0.0209
403 INTERNATIONAL NORMALISED RATIO INCREASED 596 0.0209
404 ROAD TRAFFIC ACCIDENT 874 0.0209
405 BLOOD POTASSIUM INCREASED 339 0.0209
406 BLADDER DISORDER 207 0.0208
407 LOWER GASTROINTESTINAL HAEMORRHAGE 154 0.0208
408 MIGRAINE 1986 0.0208
409 PURPURA 184 0.0208
410 DRY MOUTH 1686 0.0208
411 BOWEL MOVEMENT IRREGULARITY 159 0.0207
412 RENAL PAIN 220 0.0207
413 ABDOMINAL DISTENSION 2165 0.0207
414 RETCHING 442 0.0207
415 DYSPNOEA EXERTIONAL 780 0.0207
416 BLOOD ALBUMIN DECREASED 164 0.0207
417 NECK PAIN 1154 0.0206
418 ILEUS 256 0.0206
419 WHEEZING 1221 0.0206
420 HYPERHIDROSIS 2650 0.0205
421 ABDOMINAL PAIN 4775 0.0205
422 ORAL DISCOMFORT 285 0.0205
423 DECUBITUS ULCER 167 0.0205
424 FALL 6808 0.0204
425 SEASONAL ALLERGY 288 0.0203
426 DIABETES MELLITUS INADEQUATE CONTROL 360 0.0203
427 TOOTH FRACTURE 224 0.0203
428 BLOOD SODIUM DECREASED 383 0.0203
429 ASTHMA 2291 0.0202
430 HAEMATOMA 524 0.0202
431 BLOOD CREATININE INCREASED 1319 0.0202
432 PANCREATITIS 1064 0.0201
433 ACUTE MYOCARDIAL INFARCTION 590 0.0200
434 GASTROINTESTINAL PAIN 220 0.0200
435 SUBDURAL HAEMATOMA 286 0.0200
436 SKIN HAEMORRHAGE 296 0.0200
437 TOOTH INFECTION 263 0.0199
438 HYPOPHAGIA 509 0.0199
439 DYSGEUSIA 1479 0.0199
440 COELIAC DISEASE 195 0.0199
441 PHARYNGEAL OEDEMA 305 0.0198
442 SCIATICA 316 0.0198
443 BACK PAIN 4605 0.0198
444 JAUNDICE 533 0.0198
445 TACHYCARDIA 1756 0.0197
446 DEPRESSION 4487 0.0197
447 STENT PLACEMENT 159 0.0197
448 ACCIDENT 235 0.0197
449 UPPER GASTROINTESTINAL HAEMORRHAGE 330 0.0196
450 PHARYNGITIS 243 0.0196
451 LIVER DISORDER 868 0.0196
452 OROPHARYNGEAL PAIN 1811 0.0195
453 HAEMOLYTIC ANAEMIA 175 0.0195
454 DEEP VEIN THROMBOSIS 1268 0.0195
455 ARTHROPATHY 1082 0.0194
456 VOMITING 9148 0.0194
457 GASTROENTERITIS VIRAL 351 0.0194
458 HEPATIC CIRRHOSIS 365 0.0194
459 POLLAKIURIA 810 0.0194
460 SMALL INTESTINAL OBSTRUCTION 239 0.0194
461 WEIGHT DECREASED 5413 0.0194
462 HIP FRACTURE 622 0.0193
463 EYE HAEMORRHAGE 258 0.0193
464 ABNORMAL FAECES 158 0.0193
465 RESPIRATORY DISTRESS 531 0.0192
466 STAPHYLOCOCCAL INFECTION 634 0.0192
467 HEART RATE INCREASED 1901 0.0192
468 COUGH 5381 0.0192
469 MACULAR DEGENERATION 229 0.0192
470 PNEUMONIA BACTERIAL 176 0.0192
471 OROPHARYNGEAL DISCOMFORT 173 0.0191
472 DEFORMITY 179 0.0191
473 GOUT 343 0.0191
474 HAEMATOCHEZIA 1055 0.0191
475 GASTROINTESTINAL HAEMORRHAGE 1597 0.0191
476 COGNITIVE DISORDER 892 0.0191
477 DISTURBANCE IN ATTENTION 1028 0.0190
478 HAIR DISORDER 157 0.0190
479 SKIN LACERATION 207 0.0190
480 TOOTH DISORDER 423 0.0190
481 PRODUCTIVE COUGH 907 0.0190
482 FEELING JITTERY 362 0.0190
483 HYPERTHERMIA 145 0.0190
484 BLOOD DISORDER 152 0.0190
485 FREQUENT BOWEL MOVEMENTS 509 0.0188
486 GASTROINTESTINAL DISORDER 1687 0.0188
487 PLEURAL EFFUSION 1144 0.0188
488 LUNG INFECTION 292 0.0188
489 FEMUR FRACTURE 582 0.0188
490 FEEDING DISORDER 381 0.0188
491 OBESITY 299 0.0187
492 OXYGEN SATURATION DECREASED 1054 0.0187
493 SUDDEN DEATH 198 0.0187
494 MIOSIS 150 0.0187
495 TOOTH ABSCESS 190 0.0186
496 PNEUMOTHORAX 295 0.0186
497 SINUS TACHYCARDIA 264 0.0186
498 ASPARTATE AMINOTRANSFERASE INCREASED 986 0.0185
499 GROIN PAIN 163 0.0185
500 LIMB INJURY 503 0.0185
501 IMPAIRED QUALITY OF LIFE 266 0.0185
502 ORAL PAIN 414 0.0185
503 CARDIAC DISORDER 1729 0.0185
504 ATRIAL FIBRILLATION 1799 0.0185
505 RESPIRATORY RATE INCREASED 164 0.0185
506 SPUTUM DISCOLOURED 175 0.0184
507 ANXIETY 5244 0.0184
508 RESPIRATORY FAILURE 1343 0.0184
509 PAIN OF SKIN 494 0.0183
510 BLOOD PRESSURE INCREASED 2804 0.0183
511 RED BLOOD CELL COUNT DECREASED 524 0.0183
512 PULMONARY MASS 273 0.0183
513 CARDIO-RESPIRATORY ARREST 762 0.0182
514 INTENTIONAL PRODUCT USE ISSUE 1596 0.0182
515 ORTHOSTATIC HYPOTENSION 317 0.0182
516 DRY THROAT 185 0.0182
517 CARDIAC FAILURE 1461 0.0182
518 INCONTINENCE 192 0.0181
519 ALANINE AMINOTRANSFERASE INCREASED 1114 0.0181
520 MIDDLE INSOMNIA 338 0.0181
521 IMPAIRED HEALING 593 0.0180
522 HEAD INJURY 571 0.0180
523 LOCAL SWELLING 314 0.0180
524 UROSEPSIS 166 0.0180
525 URINARY RETENTION 600 0.0180
526 PNEUMONIA 5815 0.0179
527 BONE PAIN 1050 0.0179
528 HICCUPS 147 0.0179
529 JOINT RANGE OF MOTION DECREASED 240 0.0179
530 INSOMNIA 4763 0.0179
531 MULTI-ORGAN FAILURE 309 0.0179
532 VERTIGO 1089 0.0178
533 MYOCARDIAL INFARCTION 3110 0.0178
534 HEPATITIS 456 0.0178
535 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 855 0.0178
536 WEIGHT FLUCTUATION 186 0.0178
537 RHEUMATOID ARTHRITIS 2018 0.0178
538 ESCHERICHIA INFECTION 146 0.0177
539 WOUND INFECTION 193 0.0176
540 MYOSITIS 158 0.0176
541 HEPATOMEGALY 173 0.0176
542 CLOSTRIDIUM DIFFICILE INFECTION 383 0.0175
543 LACERATION 165 0.0175
544 ISCHAEMIC STROKE 313 0.0175
545 PAIN 10759 0.0175
546 CHROMATURIA 395 0.0175
547 EYE PRURITUS 587 0.0175
548 INITIAL INSOMNIA 179 0.0174
549 TEMPERATURE INTOLERANCE 180 0.0174
550 DIARRHOEA 11257 0.0174
551 NEURALGIA 424 0.0174
552 LIVER FUNCTION TEST ABNORMAL 506 0.0174
553 HAEMOGLOBIN DECREASED 1786 0.0174
554 PANCYTOPENIA 972 0.0174
555 PSEUDOMONAS INFECTION 149 0.0174
556 CONFUSIONAL STATE 2805 0.0173
557 LEUKOCYTOSIS 314 0.0173
558 TENDON RUPTURE 214 0.0173
559 SQUAMOUS CELL CARCINOMA 163 0.0173
560 NAUSEA 13610 0.0172
561 COLITIS 650 0.0171
562 COMA 814 0.0171
563 SYNCOPE 1709 0.0171
564 EAR DISCOMFORT 175 0.0170
565 SKIN LESION 467 0.0170
566 PULMONARY EMBOLISM 1615 0.0170
567 LACTIC ACIDOSIS 550 0.0170
568 PLATELET COUNT INCREASED 221 0.0169
569 PAIN IN JAW 480 0.0169
570 ERYTHEMA MULTIFORME 158 0.0169
571 SEPSIS 1888 0.0169
572 TENDONITIS 262 0.0169
573 CEREBRAL INFARCTION 412 0.0168
574 GASTROINTESTINAL INFECTION 151 0.0168
575 RHINORRHOEA 1087 0.0168
576 PYREXIA 5805 0.0168
577 WHITE BLOOD CELL COUNT INCREASED 643 0.0167
578 HALLUCINATION 1261 0.0167
579 CELLULITIS 843 0.0167
580 TOOTHACHE 302 0.0167
581 OSTEOMYELITIS 302 0.0167
582 CONSTIPATION 3633 0.0166
583 DYSPNOEA 9423 0.0166
584 ABASIA 411 0.0166
585 LYMPHOCYTE COUNT DECREASED 294 0.0166
586 NASAL CONGESTION 976 0.0166
587 HYPOXIA 584 0.0166
588 COLON CANCER 247 0.0166
589 FULL BLOOD COUNT ABNORMAL 175 0.0165
590 FACE OEDEMA 279 0.0165
591 POOR QUALITY SLEEP 356 0.0165
592 BACTERAEMIA 196 0.0165
593 SYSTEMIC LUPUS ERYTHEMATOSUS 586 0.0165
594 CARDIOMYOPATHY 244 0.0165
595 URINARY TRACT INFECTION 2814 0.0165
596 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 424 0.0165
597 ADVERSE EVENT 1517 0.0164
598 MYALGIA 2793 0.0164
599 GLOSSODYNIA 367 0.0164
600 CEREBROVASCULAR ACCIDENT 2775 0.0164
601 INFLAMMATION 845 0.0164
602 ELECTROCARDIOGRAM QT PROLONGED 588 0.0163
603 PULMONARY OEDEMA 732 0.0163
604 EYELID OEDEMA 190 0.0163
605 RESPIRATORY DISORDER 488 0.0163
606 NEUROPATHY PERIPHERAL 1549 0.0163
607 BLOOD LACTATE DEHYDROGENASE INCREASED 258 0.0163
608 PANIC ATTACK 593 0.0163
609 MENTAL STATUS CHANGES 450 0.0162
610 DISSEMINATED INTRAVASCULAR COAGULATION 228 0.0162
611 THROAT TIGHTNESS 438 0.0162
612 NERVOUSNESS 845 0.0162
613 FEELING ABNORMAL 3860 0.0161
614 VIRAL INFECTION 536 0.0161
615 OEDEMA 872 0.0161
616 MASS 224 0.0160
617 RESPIRATORY TRACT INFECTION 417 0.0160
618 ARTHRALGIA 6656 0.0160
619 HAIR TEXTURE ABNORMAL 214 0.0160
620 INFLUENZA 1782 0.0160
621 INCREASED TENDENCY TO BRUISE 147 0.0160
622 HEPATIC FUNCTION ABNORMAL 596 0.0160
623 DRUG LEVEL INCREASED 264 0.0159
624 HYPERBILIRUBINAEMIA 165 0.0159
625 PRURITUS GENERALISED 343 0.0158
626 ASTHENIA 5941 0.0158
627 SPLENOMEGALY 185 0.0158
628 MEMORY IMPAIRMENT 2168 0.0158
629 DECREASED APPETITE 3658 0.0157
630 PNEUMOCYSTIS JIROVECII PNEUMONIA 158 0.0157
631 DIARRHOEA HAEMORRHAGIC 147 0.0157
632 PAIN IN EXTREMITY 4633 0.0157
633 FUNGAL INFECTION 524 0.0157
634 ACUTE RESPIRATORY DISTRESS SYNDROME 278 0.0157
635 THROMBOCYTOPENIA 1757 0.0157
636 CANDIDA INFECTION 265 0.0157
637 INTESTINAL OBSTRUCTION 591 0.0157
638 BACTERIAL INFECTION 292 0.0156
639 BLOOD URINE PRESENT 297 0.0156
640 INJURY 1096 0.0156
641 HAIR COLOUR CHANGES 194 0.0156
642 COVID-19 PNEUMONIA 184 0.0156
643 MOUTH ULCERATION 328 0.0156
644 BREAST PAIN 166 0.0156
645 DRUG INTOLERANCE 1502 0.0155
646 HEART RATE DECREASED 544 0.0155
647 BLOOD PRESSURE ABNORMAL 308 0.0155
648 CHILLS 1815 0.0155
649 HEADACHE 9682 0.0154
650 MUSCLE SPASMS 2832 0.0154
651 PETECHIAE 161 0.0154
652 DRUG-INDUCED LIVER INJURY 484 0.0154
653 HYPERGLYCAEMIA 562 0.0154
654 DISORIENTATION 608 0.0153
655 LYMPHOMA 237 0.0153
656 COAGULOPATHY 255 0.0153
657 PULMONARY ARTERIAL HYPERTENSION 221 0.0152
658 EYE PAIN 860 0.0152
659 BONE LOSS 229 0.0152
660 DRUG PRESCRIBING ERROR 292 0.0152
661 CONTUSION 1463 0.0152
662 BLOOD CREATINE PHOSPHOKINASE INCREASED 437 0.0152
663 MULTIPLE ORGAN DYSFUNCTION SYNDROME 428 0.0151
664 SWELLING FACE 983 0.0151
665 FEBRILE NEUTROPENIA 1001 0.0151
666 DERMATITIS CONTACT 172 0.0151
667 PHOTOSENSITIVITY REACTION 249 0.0151
668 SCAR 258 0.0151
669 LIMB DISCOMFORT 465 0.0150
670 JOINT STIFFNESS 394 0.0150
671 SALIVARY HYPERSECRETION 150 0.0150
672 DEAFNESS 392 0.0150
673 DELIRIUM 519 0.0149
674 DISCOMFORT 912 0.0149
675 BALANCE DISORDER 1292 0.0149
676 DRY EYE 745 0.0149
677 HYPOACUSIS 640 0.0149
678 ENCEPHALOPATHY 365 0.0148
679 HERPES ZOSTER 854 0.0148
680 BONE MARROW FAILURE 302 0.0148
681 BLOOD BILIRUBIN INCREASED 400 0.0148
682 METASTASES TO LIVER 260 0.0148
683 FRACTURE 280 0.0148
684 NEOPLASM MALIGNANT 987 0.0148
685 HUNGER 206 0.0148
686 INFUSION RELATED REACTION 980 0.0148
687 GENERAL PHYSICAL HEALTH DETERIORATION 1709 0.0148
688 STEVENS-JOHNSON SYNDROME 328 0.0147
689 CONVULSION 842 0.0147
690 LYMPHADENOPATHY 520 0.0147
691 FLUID RETENTION 746 0.0147
692 EAR INFECTION 390 0.0146
693 NODULE 191 0.0146
694 WRONG TECHNIQUE IN DRUG USAGE PROCESS 531 0.0146
695 DIZZINESS 7285 0.0146
696 ARRHYTHMIA 691 0.0146
697 POST PROCEDURAL COMPLICATION 280 0.0146
698 DEMENTIA 407 0.0145
699 COLD SWEAT 256 0.0145
700 DRUG EFFECT DECREASED 780 0.0145
701 PRODUCT USE ISSUE 2716 0.0144
702 FLUSHING 1465 0.0144
703 CONTRAINDICATED PRODUCT ADMINISTERED 436 0.0144
704 POOR VENOUS ACCESS 149 0.0144
705 HYPOTENSION 2888 0.0144
706 HEPATIC FAILURE 433 0.0143
707 EYE INFECTION 162 0.0143
708 THINKING ABNORMAL 267 0.0143
709 NASOPHARYNGITIS 2639 0.0143
710 PLATELET COUNT DECREASED 1522 0.0143
711 JOINT SWELLING 1716 0.0142
712 HYPOAESTHESIA 2127 0.0142
713 BLOOD COUNT ABNORMAL 215 0.0142
714 IMPAIRED DRIVING ABILITY 161 0.0142
715 HYPERTHYROIDISM 205 0.0141
716 BLOOD PRESSURE DECREASED 937 0.0141
717 ANHEDONIA 370 0.0141
718 BODY TEMPERATURE INCREASED 287 0.0141
719 ANAPHYLACTIC REACTION 776 0.0140
720 SOMNOLENCE 2825 0.0140
721 PARAESTHESIA 2205 0.0140
722 SLEEP DISORDER 988 0.0140
723 MUSCULOSKELETAL STIFFNESS 1224 0.0140
724 SPEECH DISORDER 732 0.0140
725 LOSS OF CONSCIOUSNESS 1785 0.0139
726 ATAXIA 165 0.0139
727 WEIGHT INCREASED 3113 0.0139
728 HYPOGLYCAEMIA 673 0.0139
729 RASH PRURITIC 752 0.0139
730 PHARMACEUTICAL PRODUCT COMPLAINT 360 0.0138
731 ABNORMAL DREAMS 380 0.0137
732 GLOMERULAR FILTRATION RATE DECREASED 169 0.0137
733 INTESTINAL PERFORATION 154 0.0137
734 NIGHT SWEATS 442 0.0137
735 INFLUENZA LIKE ILLNESS 1129 0.0137
736 EJECTION FRACTION DECREASED 213 0.0137
737 TREMOR 2259 0.0136
738 THERAPEUTIC RESPONSE UNEXPECTED 610 0.0136
739 VENTRICULAR FIBRILLATION 151 0.0136
740 OSTEONECROSIS OF JAW 336 0.0136
741 BRADYCARDIA 717 0.0135
742 DEVICE RELATED INFECTION 208 0.0135
743 MUSCLE ATROPHY 171 0.0135
744 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 739 0.0135
745 SHOCK 309 0.0134
746 CONJUNCTIVITIS 249 0.0134
747 PERIPHERAL SWELLING 2065 0.0134
748 SPINAL PAIN 157 0.0134
749 HEPATIC ENZYME INCREASED 911 0.0134
750 STOMATITIS 810 0.0133
751 FEELING HOT 818 0.0133
752 GAIT DISTURBANCE 2550 0.0133
753 HOT FLUSH 1004 0.0133
754 POST PROCEDURAL HAEMORRHAGE 155 0.0133
755 HYPERTENSIVE CRISIS 148 0.0133
756 PNEUMONITIS 362 0.0133
757 ACCIDENTAL OVERDOSE 485 0.0132
758 HALLUCINATION, VISUAL 279 0.0132
759 MEDICATION ERROR 734 0.0132
760 FLUID OVERLOAD 192 0.0132
761 TOOTH EXTRACTION 164 0.0132
762 NEUTROPHIL COUNT DECREASED 537 0.0132
763 ABSCESS 210 0.0131
764 METASTASES TO BONE 216 0.0131
765 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 935 0.0131
766 VISUAL IMPAIRMENT 1624 0.0131
767 IMMUNE SYSTEM DISORDER 172 0.0130
768 NEOPLASM 150 0.0130
769 CEREBRAL HAEMORRHAGE 466 0.0130
770 LYMPHOPENIA 184 0.0130
771 ECZEMA 679 0.0130
772 THROMBOSIS 1040 0.0129
773 HEPATITIS C 156 0.0129
774 SENSORY DISTURBANCE 207 0.0129
775 MENTAL DISORDER 561 0.0129
776 FATIGUE 10022 0.0129
777 VISION BLURRED 1766 0.0128
778 MUSCLE TIGHTNESS 208 0.0128
779 SKIN DISORDER 428 0.0128
780 PERIPHERAL COLDNESS 176 0.0128
781 LOWER RESPIRATORY TRACT INFECTION 582 0.0128
782 SYNOVITIS 230 0.0127
783 CONDITION AGGRAVATED 3878 0.0127
784 CARDIOGENIC SHOCK 183 0.0127
785 DYSSTASIA 371 0.0127
786 HYPOKINESIA 184 0.0127
787 RASH GENERALISED 327 0.0126
788 ORAL HERPES 246 0.0126
789 HYPERSENSITIVITY 2337 0.0126
790 ILL-DEFINED DISORDER 763 0.0125
791 BEDRIDDEN 165 0.0125
792 EPISTAXIS 939 0.0125
793 PRESCRIBED UNDERDOSE 250 0.0125
794 CRYING 455 0.0125
795 BRONCHOSPASM 178 0.0125
796 MOBILITY DECREASED 896 0.0125
797 ERECTILE DYSFUNCTION 320 0.0124
798 FEAR 335 0.0124
799 GINGIVAL BLEEDING 170 0.0124
800 ACUTE HEPATIC FAILURE 170 0.0124
801 DYSKINESIA 505 0.0124
802 LETHARGY 714 0.0124
803 SUICIDE ATTEMPT 752 0.0124
804 SECRETION DISCHARGE 155 0.0124
805 LEUKOPENIA 619 0.0124
806 COLITIS ULCERATIVE 553 0.0124
807 PRODUCT TASTE ABNORMAL 167 0.0123
808 MOVEMENT DISORDER 395 0.0123
809 MUCOSAL INFLAMMATION 321 0.0122
810 PRURITUS 4691 0.0122
811 INCORRECT DRUG ADMINISTRATION DURATION 343 0.0122
812 MUSCULOSKELETAL DISORDER 230 0.0121
813 SWELLING 1130 0.0121
814 BLINDNESS UNILATERAL 170 0.0120
815 HYPERSOMNIA 345 0.0120
816 ABDOMINAL PAIN LOWER 304 0.0120
817 VISUAL ACUITY REDUCED 399 0.0120
818 LOCALISED INFECTION 289 0.0119
819 WHITE BLOOD CELL COUNT DECREASED 1295 0.0119
820 THIRST 213 0.0119
821 INJECTION SITE EXTRAVASATION 146 0.0118
822 INFECTION 1709 0.0118
823 BRAIN OEDEMA 149 0.0118
824 PARAESTHESIA ORAL 170 0.0118
825 MENTAL IMPAIRMENT 285 0.0117
826 HYPOAESTHESIA ORAL 177 0.0117
827 BLOOD GLUCOSE INCREASED 2203 0.0117
828 HIP ARTHROPLASTY 179 0.0117
829 UNRESPONSIVE TO STIMULI 301 0.0117
830 DEPRESSED MOOD 614 0.0116
831 RASH MACULAR 404 0.0115
832 CARDIOVASCULAR DISORDER 292 0.0115
833 INCREASED APPETITE 219 0.0114
834 TRANSAMINASES INCREASED 254 0.0114
835 ALOPECIA 2241 0.0114
836 TACHYPNOEA 155 0.0114
837 CYANOSIS 179 0.0114
838 DRUG EFFECT INCOMPLETE 411 0.0113
839 CARDIAC ARREST 933 0.0113
840 PELVIC PAIN 205 0.0113
841 DISEASE RECURRENCE 533 0.0112
842 RESTLESSNESS 410 0.0112
843 MYELODYSPLASTIC SYNDROME 162 0.0112
844 INJECTION SITE HAEMATOMA 162 0.0112
845 AGEUSIA 278 0.0111
846 DEPRESSED LEVEL OF CONSCIOUSNESS 440 0.0111
847 OFF LABEL USE 9728 0.0111
848 CIRCULATORY COLLAPSE 188 0.0110
849 BLOOD GLUCOSE DECREASED 530 0.0110
850 FEELING COLD 307 0.0110
851 DRUG TOXICITY 150 0.0110
852 EYE DISORDER 362 0.0110
853 DRUG INEFFECTIVE 14500 0.0110
854 LIVER INJURY 270 0.0110
855 KNEE ARTHROPLASTY 231 0.0110
856 HALLUCINATION, AUDITORY 174 0.0109
857 BLISTER 613 0.0109
858 GLYCOSYLATED HAEMOGLOBIN INCREASED 273 0.0108
859 THERAPEUTIC PRODUCT EFFECT DECREASED 484 0.0108
860 AGITATION 793 0.0108
861 ANAPHYLACTIC SHOCK 278 0.0108
862 WOUND 301 0.0108
863 EMOTIONAL DISORDER 332 0.0108
864 EPILEPSY 329 0.0108
865 PARANOIA 185 0.0107
866 INSURANCE ISSUE 164 0.0107
867 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 759 0.0107
868 PALLOR 290 0.0106
869 NEUTROPENIA 1449 0.0106
870 RASH 4604 0.0106
871 HAEMORRHAGE 1104 0.0105
872 CYTOKINE RELEASE SYNDROME 209 0.0104
873 APATHY 151 0.0103
874 RASH ERYTHEMATOUS 494 0.0103
875 LUNG NEOPLASM MALIGNANT 421 0.0102
876 ERYTHEMA 2105 0.0102
877 URTICARIA 1700 0.0101
878 PERITONITIS 209 0.0101
879 PRODUCT SUBSTITUTION ISSUE 581 0.0101
880 SKIN DISCOLOURATION 462 0.0100
881 DRUG DISPENSING ERROR 153 0.0100
882 COVID-19 1753 0.0100
883 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 232 0.0099
884 INTENTIONAL OVERDOSE 635 0.0099
885 CYTOMEGALOVIRUS INFECTION 164 0.0099
886 IMMUNODEFICIENCY 147 0.0099
887 FULL BLOOD COUNT DECREASED 197 0.0098
888 ADVERSE DRUG REACTION 878 0.0098
889 PRESCRIBED OVERDOSE 188 0.0097
890 TOOTH LOSS 200 0.0096
891 EYE SWELLING 358 0.0096
892 DRUG ADMINISTRATION ERROR 294 0.0096
893 RESPIRATORY ARREST 264 0.0096
894 INCORRECT PRODUCT ADMINISTRATION DURATION 207 0.0095
895 NERVOUS SYSTEM DISORDER 298 0.0095
896 LACRIMATION INCREASED 288 0.0095
897 IRRITABILITY 571 0.0095
898 SKIN CANCER 204 0.0095
899 PRODUCT PHYSICAL ISSUE 190 0.0094
900 DISABILITY 185 0.0093
901 DERMATITIS 196 0.0093
902 GENERALISED TONIC-CLONIC SEIZURE 154 0.0093
903 SUICIDAL IDEATION 845 0.0092
904 HEPATOTOXICITY 205 0.0092
905 OSTEONECROSIS 301 0.0092
906 BLOOD GLUCOSE ABNORMAL 169 0.0091
907 MALIGNANT NEOPLASM PROGRESSION 934 0.0091
908 MANIA 150 0.0091
909 DIABETIC KETOACIDOSIS 218 0.0091
910 MULTIPLE SCLEROSIS 420 0.0088
911 ANGER 297 0.0088
912 SKIN EXFOLIATION 728 0.0086
913 SURGERY 498 0.0085
914 THERAPEUTIC RESPONSE DECREASED 515 0.0085
915 ABNORMAL BEHAVIOUR 334 0.0084
916 DRUG DEPENDENCE 1349 0.0084
917 UNEVALUABLE EVENT 633 0.0084
918 PROCEDURAL PAIN 232 0.0084
919 PRODUCT USE IN UNAPPROVED INDICATION 2068 0.0083
920 TASTE DISORDER 169 0.0083
921 MOOD ALTERED 226 0.0083
922 EYE IRRITATION 473 0.0082
923 DISEASE PROGRESSION 972 0.0082
924 PLASMA CELL MYELOMA 318 0.0081
925 PRODUCT QUALITY ISSUE 1093 0.0080
926 DRY SKIN 1070 0.0080
927 EXTRAPYRAMIDAL DISORDER 199 0.0080
928 TARDIVE DYSKINESIA 226 0.0080
929 TREATMENT NONCOMPLIANCE 437 0.0080
930 PSORIASIS 1042 0.0080
931 EMOTIONAL DISTRESS 930 0.0077
932 OCULAR HYPERAEMIA 364 0.0077
933 PSORIATIC ARTHROPATHY 308 0.0076
934 MOOD SWINGS 240 0.0075
935 PANCREATIC CARCINOMA 215 0.0074
936 AGGRESSION 372 0.0074
937 LABORATORY TEST ABNORMAL 218 0.0074
938 INCORRECT DOSE ADMINISTERED 1674 0.0073
939 THERAPY CESSATION 367 0.0071
940 PSYCHOTIC DISORDER 210 0.0071
941 WITHDRAWAL SYNDROME 297 0.0071
942 OESOPHAGEAL CARCINOMA 209 0.0070
943 GAIT INABILITY 231 0.0069
944 SEIZURE 793 0.0069
945 LIVER FUNCTION TEST INCREASED 147 0.0068
946 PRODUCT PRESCRIBING ERROR 158 0.0066
947 NEOPLASM PROGRESSION 229 0.0066
948 DEATH 5661 0.0066
949 BREAST CANCER 605 0.0065
950 BREAST CANCER FEMALE 170 0.0064
951 INJECTION SITE HAEMORRHAGE 502 0.0063
952 INJECTION SITE BRUISING 498 0.0062
953 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1117 0.0062
954 INJECTION SITE REACTION 423 0.0061
955 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 204 0.0060
956 ILLNESS 612 0.0059
957 TREATMENT FAILURE 489 0.0059
958 THERAPY NON-RESPONDER 265 0.0059
959 INJECTION SITE ERYTHEMA 728 0.0059
960 OVERDOSE 1244 0.0058
961 INJECTION SITE PAIN 1760 0.0057
962 INJECTION SITE PRURITUS 383 0.0057
963 HOSPITALISATION 877 0.0057
964 INJECTION SITE MASS 208 0.0056
965 PRODUCT DOSE OMISSION 366 0.0056
966 EXPIRED PRODUCT ADMINISTERED 183 0.0055
967 TOXICITY TO VARIOUS AGENTS 925 0.0055
968 MULTIPLE SCLEROSIS RELAPSE 352 0.0051
969 DRUG WITHDRAWAL SYNDROME 450 0.0051
970 INJECTION SITE RASH 157 0.0051
971 UNDERDOSE 363 0.0050
972 RENAL CANCER 230 0.0048
973 VAGINAL HAEMORRHAGE 208 0.0048
974 INJECTION SITE SWELLING 341 0.0044
975 DEVICE MALFUNCTION 311 0.0044
976 ACNE 328 0.0043
977 SKIN BURNING SENSATION 301 0.0042
978 EXPOSURE DURING PREGNANCY 257 0.0041
979 PRODUCT ADHESION ISSUE 147 0.0041
980 INCORRECT ROUTE OF DRUG ADMINISTRATION 146 0.0041
981 DEVICE ISSUE 357 0.0040
982 PRODUCT DOSE OMISSION ISSUE 1170 0.0040
983 EXTRA DOSE ADMINISTERED 155 0.0038
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 730 0.0036
985 MATERNAL EXPOSURE DURING PREGNANCY 309 0.0035
986 DEVICE DISLOCATION 147 0.0034
987 DRUG ABUSE 273 0.0033
988 FOETAL EXPOSURE DURING PREGNANCY 263 0.0032
989 COMPLETED SUICIDE 267 0.0032
990 THERAPY INTERRUPTED 226 0.0032
991 PROSTATE CANCER 251 0.0031
992 NO ADVERSE EVENT 335 0.0018
993 ACCIDENTAL EXPOSURE TO PRODUCT 167 0.0016